Alex Miller is a Senior Associate on the Venture team at RA Capital Management, where he focuses on creating and investing in early-stage biotechnology companies. He works closely with founders and management teams on company formation, therapeutic strategy, and development planning across a range of disease areas and therapeutic modalities. Alex holds a PhD in Medical Engineering and Medical Physics from the Harvard-MIT Health Sciences and Technology Program and a BS in Bioengineering from Harvard University.
